𝔖 Scriptorium
✦   LIBER   ✦

πŸ“

Multiple Sclerosis and Demyelinating Diseases

✍ Scribed by Mark Freedman MD


Publisher
LWW
Year
2005
Tongue
English
Leaves
391
Series
Advances in Neurology
Edition
1
Category
Library

⬇  Acquire This Volume

No coin nor oath required. For personal study only.

✦ Synopsis


This volume in the distinguished Advances in Neurology series focuses on multiple sclerosis and related demyelinating diseases. An international group of experts examines recent developments in diagnosis, treatment, and other aspects of clinical management. The latest cutting-edge research on the causes and mechanisms of these diseases is also discussed.

Coverage includes detailed discussions on new diagnostic methods and the role of neuroimaging in diagnosis. Chapters present evidence-based treatment protocols and review current clinical testing of new therapies.

✦ Subjects


Multiple Sclerosis;Diseases & Physical Ailments;Health, Fitness & Dieting;Neurology;Alzheimer’s Disease;Headache;Neuroscience;Internal Medicine;Medicine;Diseases;AIDS & HIV;Brain;Cancer;Cardiovascular;Communicable Diseases;Diabetes;Digestive Organs;Extremities;Psoriasis;Viral;Pathology;Internal Medicine;Medicine


πŸ“œ SIMILAR VOLUMES


Myelination and Demyelination: Implicati
✍ Seung U. Kim (auth.), Seung U. Kim (eds.) πŸ“‚ Library πŸ“… 1989 πŸ› Springer US 🌐 English

<p>In June 1987, neurobiologists, immunologists, molecular biologists, virologists and neurologists from several countries met in Vancouver to discuss recent advances of relevance to multiple sclerosis. The symposium was a part of the 22nd Canadian Congress of Neurological Sciences meeting and was s

Advances in Multiple Sclerosis and Exper
✍ Moses Rodriguez, Moses Rodriguez πŸ“‚ Library πŸ“… 2007 πŸ› Springer 🌐 English

<P>There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis.</P> <P>Challenging Charcot s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and possible

Advances in multiple Sclerosis and Exper
✍ S. J. Pittock, M. Rodriguez (auth.), Moses Rodriguez (eds.) πŸ“‚ Library πŸ“… 2008 πŸ› Springer-Verlag Berlin Heidelberg 🌐 English

<p><P>"There is a need for a paradigm shift in our thinking about the pathogenesis of multiple sclerosis."</P><P></P><P>Challenging Charcot’s hypothesis that inflammatory response is the primary contributor to demyelination, Dr. Rodriguez and colleagues take a fresh, bold look at the causes and poss

Common Pitfalls in Multiple Sclerosis an
✍ B. Mark Keegan πŸ“‚ Library πŸ“… 2016 πŸ› Cambridge University Press 🌐 English

Differentiating multiple sclerosis (MS) from alternative demyelinating diseases of the central nervous system and systemic medical conditions that mimic MS is challenging. A simple three-step approach is used in this text to guide readers through clinical cases to define MS and rule out competing ca

Myelin Repair and Neuroprotection in Mul
✍ Robert H. Miller (auth.), Ian D. Duncan, Robin J M Franklin (eds.) πŸ“‚ Library πŸ“… 2013 πŸ› Springer US 🌐 English

<p><p><b><i>Myelin Repair and Neuroprotection in Multiple Sclerosis</i></b> presents an up-date on the translational potential of promoting remyelination in multiple sclerosis (MS). A number of research frontiers still exist in this challenging disease. The cause remains elusive, preventing breakthr

Myelination and Demyelination
✍ Elizabeth Roboz Einstein (auth.), Jorma Palo (eds.) πŸ“‚ Library πŸ“… 1978 πŸ› Springer US 🌐 English

<p>A satellite symposium entitled "Myelination and Demyelination: Recent Chemical Advances" was held in Helsinki from August 29 to 31, 1977, after the Sixth International Meeting of the International Society for Neurochemistry (ISN) in Copenhagen. Myelin is a nervous tissue structure that is most su